HEPARIN Side Effects

7023510-X | Thrombocytopenia
on Sep 29, 2010 Male patient from UNITED STATES , 49 years of age, weighting 257.9 lb, was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Heparin dosage: 5000 Units Tid Sq.

6983461-3 | Cholecystitis Acute, Hypotension, Thrombocytopenia
Patient was taking Heparin (View Usage). Patient had the following side effects: cholecystitis acute, hypotension, thrombocytopenia on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 134.2 lb, was diagnosed with thrombosis prophylaxis and. Heparin dosage: 5000 Units Tid Sq.

6981382-3 | Heparin-induced Thrombocytopenia
Adverse event was reported on Sep 03, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, After Heparin was administered, patient had the following side effects: heparin-induced thrombocytopenia.

6981378-1 | Haemorrhage Intracranial, Heparin-induced Thrombocytopenia
on Sep 03, 2010 Male patient from UNITED STATES , 51 years of age, was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial, heparin-induced thrombocytopenia. Heparin dosage: .


6981355-0 | Gastrointestinal Haemorrhage, Heparin-induced Thrombocytopenia
on Sep 03, 2010 Male patient from UNITED STATES , 87 years of age, was diagnosed with aortic valve replacement and was treated with Heparin (View Usage). Patient had the following side effects: gastrointestinal haemorrhage, heparin-induced thrombocytopenia. Heparin dosage: .

6962233-X | Epistaxis, Haemorrhage
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: epistaxis, haemorrhage on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 176.4 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Heparin dosage: 5000 Units Every Day Sq.

6943100-4 | Anaemia, Gastric Haemorrhage
Adverse event was reported on Aug 25, 2010 by a Male patient taking Heparin (View Usage) (Dosage: 5000 Units Bid Sq) was diagnosed with cerebrovascular accident prophylaxis and. Location: UNITED STATES , 78 years of age, weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: anaemia, gastric haemorrhage. During the same period patient was treated with ASPIRIN (81 Mg Every Day Other) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6935918-9 | Anti-platelet Antibody Positive, Heparin-induced Thrombocytopenia Test, Thrombosis
on Aug 19, 2010 Male patient from UNITED STATES , 62 years of age, weighting 116.8 lb, was diagnosed with myocardial infarction and was treated with Heparin (View Usage). Patient had the following side effects: anti-platelet antibody positive, heparin-induced thrombocytopenia test, thrombosis. Heparin dosage: 14000 Units Every Day Iv. Patient was hospitalized.

6927843-4 | Product Measured Potency Issue, Product Quality Issue
on Aug 16, 2010 Female patient from UNITED STATES , 58 years of age, weighting 145.5 lb, was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: product measured potency issue, product quality issue. Heparin dosage: . Patient was hospitalized.

6925942-4 | Heparin-induced Thrombocytopenia
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , 78 years of age, . Heparin dosage: 5000 Units Tid Sq. During the same period patient was treated with HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% (View Heparin Sodium 1,000 Units In Sodium Chloride 0.9% Review and Heparin Sodium 1,000 Units In Sodium Chloride 0.9% Label ). Patient was hospitalized.

6915248-1 | Anaphylactic Reaction, Anaphylactoid Reaction, Chest Pain
Adverse event was reported on Aug 06, 2010 by a Male patient taking Heparin (View Usage) (Dosage: 3000 Units X1 Iv Bolus (1 Dose)) was diagnosed with catheterisation cardiac and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: anaphylactic reaction, anaphylactoid reaction, chest pain (What is chest pain?). During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), GLUCOSAMINE CHONDROITIN (View Glucosamine Chondroitin Review and Glucosamine Chondroitin Label ), NEXIUM (View Nexium Review and Nexium Label ), UROXATRAL (View Uroxatral Review and Uroxatral Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ). Patient was hospitalized.

6894733-5 | Antibody Test Positive, Deep Vein Thrombosis, Platelet Count Decreased
on Jul 30, 2010 Female patient from UNITED STATES , weighting 115.1 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), thrombosis prophylaxis and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: antibody test positive, deep vein thrombosis (What is deep vein thrombosis?), platelet count decreased. Heparin dosage: 500 Units Hourly Iv. During the same period patient was treated with DALTEPARIN SODIUM (5,000 Units Daily Sq) (View Dalteparin Sodium Review and Dalteparin Sodium Label ).

6885296-9 | Extradural Haematoma, Paralysis, Sensory Loss
on Jul 29, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: extradural haematoma, paralysis (What is paralysis?), sensory loss. Heparin dosage: .

6883027-X | Catheter Site Haematoma, Catheter Site Haemorrhage, Heparin-induced Thrombocytopenia, Tracheal Haemorrhage
Patient was taking Heparin (View Usage). Patient had the following side effects: catheter site haematoma, catheter site haemorrhage, heparin-induced thrombocytopenia, tracheal haemorrhage on Jul 13, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 31 years of age, . Heparin dosage: . During the same period patient was treated with LEPIRUDIN (View Lepirudin Review and Lepirudin Label ).

6882012-1 | Heparin-induced Thrombocytopenia Test, Laboratory Test Abnormal
Adverse event was reported on Jul 28, 2010 by a Male patient taking Heparin (View Usage) (Dosage: 580-780 Units/hr Continuous Iv Infusion) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Location: UNITED STATES , weighting 142.2 lb, After Heparin was administered, patient had the following side effects: heparin-induced thrombocytopenia test, laboratory test abnormal.

6881439-1 | Product Measured Potency Issue, Product Quality Issue
on Jul 28, 2010 Male patient from UNITED STATES , weighting 176.4 lb, was diagnosed with aortic aneurysm (What is aortic aneurysm?) and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: product measured potency issue, product quality issue. Heparin dosage: 12,000 Units Once Iv.

6874564-2 | Antinuclear Antibody Positive, Bacteroides Test Positive, Blood Pressure Diastolic Decreased, Bone Erosion, Bronchoalveolar Lavage Abnormal, Carbon Monoxide Diffusing Capacity Decreased, Cardiac Murmur, Cardiomegaly, Chest Pain
on Jul 08, 2010 Male patient from BELGIUM , 64 years of age, was diagnosed with acute coronary syndrome and was treated with Heparin (View Usage). Patient had the following side effects: antinuclear antibody positive, bacteroides test positive, blood pressure diastolic decreased, bone erosion, bronchoalveolar lavage abnormal, carbon monoxide diffusing capacity decreased, cardiac murmur, cardiomegaly, chest pain (What is chest pain?). Heparin dosage: Solution Nos; Intravenous (not Otherwise Specified); Continuous. During the same period patient was treated with ASPIRIN (See Image) (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (600 Milligram (s); Tablet; Oral;daily) (View Clopidogrel Review and Clopidogrel Label ), EPTIFIBATIDE (EPTIFIBATIDE) (Intravenous) (View Eptifibatide (eptifibatide) Review and Eptifibatide (eptifibatide) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), MOLSIDOMINE (MOLSIDOMINE) (View Molsidomine (molsidomine) Review and Molsidomine (molsidomine) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

6874485-5 | Mediastinal Haematoma, Mediastinal Haemorrhage, Respiratory Distress
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: mediastinal haematoma, mediastinal haemorrhage, respiratory distress on Jul 23, 2010 from UNITED STATES Additional patient health information: Male patient , 80 years of age, . Heparin dosage: 25000 Units Iv Drip. During the same period patient was treated with WARFARIN SODIUM (Warfarin 5 Mg Daily Po) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6867548-1 | Chest Pain, Fall, Heparin-induced Thrombocytopenia, Oxygen Saturation Decreased
Adverse event was reported on Jul 15, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), fall (What is fall?), heparin-induced thrombocytopenia, oxygen saturation decreased.

6844240-0 | Heparin-induced Thrombocytopenia
on Jul 14, 2010 Male patient from UNITED STATES , 63 years of age, weighting 210.1 lb, was diagnosed with catheterisation cardiac, coronary arterial stent insertion, coronary artery disease (What is coronary artery disease?) and was treated with Heparin (View Usage). Patient had the following side effects: heparin-induced thrombocytopenia. Heparin dosage: 5000 Units Once Iv. During the same period patient was treated with EPTIFIBATIDE (15 Ml Per Hour Iv) (View Eptifibatide Review and Eptifibatide Label ). Patient was hospitalized.

6822464-6 | Diplegia, Extradural Haematoma, Spinal Compression Fracture
on Jul 07, 2010 Female patient from UNITED STATES , weighting 198.4 lb, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: diplegia, extradural haematoma, spinal compression fracture. Heparin dosage: Drip. During the same period patient was treated with LOVENOX (90mg Qday -lovenox- Sq) (View Lovenox Review and Lovenox Label ), WARFARIN SODIUM (2.5mg, 2.5mg, 5mg Qday Po) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6822078-8 | Catheter Site Discharge, Heparin-induced Thrombocytopenia
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: catheter site discharge, heparin-induced thrombocytopenia on Jul 06, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 174.2 lb, was diagnosed with coronary arterial stent insertion and. Heparin dosage: 6500 Units Once Iv. Patient was hospitalized.

6809782-2 | Skin Flap Necrosis, Thrombocytopenia, Thrombosis
Adverse event was reported on Jun 23, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) was diagnosed with prophylaxis and. Location: UNITED STATES , 44 years of age, Patient had the following side effects: skin flap necrosis, thrombocytopenia, thrombosis. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LOVENOX (View Lovenox Review and Lovenox Label ).

6785692-4 | Diverticulum, Faecaloma, Neoplasm Malignant
on Jun 21, 2010 Female patient from UNITED STATES , 67 years of age, weighting 284.4 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: diverticulum, faecaloma, neoplasm malignant. Heparin dosage: 5000units Q8 Sq Chronic. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), INSULIN (View Insulin Review and Insulin Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), NEXIUM (View Nexium Review and Nexium Label ), SIMVASTIN (View Simvastin Review and Simvastin Label ), VIT C (View Vit C Review and Vit C Label ), HYDROCODONE BITARTRATE AND ACETAMINOPHEN (View Hydrocodone Bitartrate And Acetaminophen Review and Hydrocodone Bitartrate And Acetaminophen Label ). Patient was hospitalized.

6785515-3 | Atrial Fibrillation, Chest Pain, Cyanosis, Extremity Necrosis, Finger Amputation, Gangrene, Haemodynamic Instability, Heparin-induced Thrombocytopenia, Hypotension
on Jun 21, 2010 Male patient from UNITED STATES , 81 years of age, weighting 150.1 lb, was diagnosed with coronary artery bypass (What is coronary artery bypass?), intravenous catheter management and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), chest pain (What is chest pain?), cyanosis, extremity necrosis, finger amputation, gangrene, haemodynamic instability, heparin-induced thrombocytopenia, hypotension. Heparin dosage: Various Various Iv. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), AMBIEN (View Ambien Review and Ambien Label ), .. (View .. Review and .. Label ). Patient was hospitalized.

6782275-7 | Heparin-induced Thrombocytopenia, Transient Global Amnesia
Patient was taking Heparin (View Usage). Patient had the following side effects: heparin-induced thrombocytopenia, transient global amnesia on Jun 10, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 57 years of age, was diagnosed with prophylaxis and. Heparin dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6770274-0 | Arterial Thrombosis Limb, Arthritis, Cerebral Infarction, Dysarthria, Exostosis, Finger Amputation, Gout, Heparin-induced Thrombocytopenia, Hyperhidrosis
Adverse event was reported on May 10, 2010 by a Male patient taking Heparin (View Usage) (Dosage: Iv Bolus) . Location: UNITED STATES , 70 years of age, After Heparin was administered, patient had the following side effects: arterial thrombosis limb, arthritis (What is arthritis?), cerebral infarction, dysarthria, exostosis, finger amputation, gout (What is gout?), heparin-induced thrombocytopenia, hyperhidrosis. During the same period patient was treated with FRAGMIN (Subcutaneous) (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

6760713-3 | Operative Haemorrhage, Small Intestinal Haemorrhage, Thrombosis
on Jun 07, 2010 Female patient from UNITED STATES , 70 years of age, weighting 164.0 lb, was diagnosed with coronary artery bypass (What is coronary artery bypass?) and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: operative haemorrhage, small intestinal haemorrhage, thrombosis. Heparin dosage: .

6752559-7 | Uterine Haematoma
on May 26, 2010 Female patient from UNITED STATES , 22 years of age, was diagnosed with prophylaxis and was treated with Heparin (View Usage). Patient had the following side effects: uterine haematoma. Heparin dosage: .

6742805-8 | Arterial Thrombosis Limb, Brain Herniation, Cerebral Infarction, Cerebral Ventricle Dilatation, Cyanosis, Deep Vein Thrombosis, Exostosis, Finger Amputation, Gout
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: arterial thrombosis limb, brain herniation, cerebral infarction, cerebral ventricle dilatation, cyanosis, deep vein thrombosis (What is deep vein thrombosis?), exostosis, finger amputation, gout (What is gout?) on May 10, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, . Heparin dosage: Iv Bolus. During the same period patient was treated with FRAGMIN (Subcutaneous) (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

6741818-X | Heparin-induced Thrombocytopenia, Intestinal Ischaemia, Mesenteric Artery Thrombosis
Adverse event was reported on May 18, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 56 years of age, Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia, intestinal ischaemia, mesenteric artery thrombosis. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), DANAPAROID (View Danaparoid Review and Danaparoid Label ).

6740824-9 | Acute Myocardial Infarction, Brain Herniation, Cerebral Haemorrhage, Heart Rate Decreased, Unresponsive To Stimuli
on May 25, 2010 Female patient from UNITED STATES , 52 years of age, weighting 218.3 lb, was diagnosed with myocardial infarction and was treated with Heparin (View Usage). Patient had the following side effects: acute myocardial infarction, brain herniation, cerebral haemorrhage, heart rate decreased, unresponsive to stimuli. Heparin dosage: 1000 Units Per Hour Iv Drip.

6736379-5 | Pulmonary Embolism
on May 20, 2010 Female patient from UNITED STATES , 66 years of age, weighting 94.80 lb, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Heparin dosage: 5000 Units Q8 Sq. Patient was hospitalized.

6731627-X | Post Procedural Haemorrhage
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: post procedural haemorrhage on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), cerebrovascular accident, pulmonary embolism (What is pulmonary embolism?) and. Heparin dosage: 950 Units/hr Continuous Iv Drip.

6725408-0 | Aphasia, Cerebellar Haemorrhage, Disease Complication, Transient Ischaemic Attack
Adverse event was reported on May 13, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 204.0 lb, Patient had the following side effects: aphasia (What is aphasia?), cerebellar haemorrhage, disease complication, transient ischaemic attack. During the same period patient was treated with TOSHIBA (View Toshiba Review and Toshiba Label ).

6723285-5 | No Adverse Event
on May 12, 2010 Male patient from UNITED STATES , 47 years of age, weighting 218.3 lb, was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: no adverse event. Heparin dosage: 40k Bolus For Initial Heparin Intermittent Bolus Of 5k -10 Units At A Time To Maintain.

6720545-9 | No Adverse Event
on May 11, 2010 Male patient from UNITED STATES , 47 years of age, weighting 218.3 lb, was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Heparin dosage: Varies. Patient was hospitalized.

6717593-1 | Gangrene, Leg Amputation, Sepsis, Thrombosis
Patient was taking Heparin (View Usage). Patient had the following side effects: gangrene, leg amputation, sepsis (What is sepsis?), thrombosis on May 07, 2010 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 175.0 lb, was diagnosed with thrombosis prophylaxis and. Heparin dosage: Inject 1 Ml Three Time Daily Intraperitoneal. Patient was hospitalized.

6715728-8 | Heparin-induced Thrombocytopenia, Intestinal Ischaemia, Mesenteric Artery Thrombosis
Adverse event was reported on Apr 30, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) was diagnosed with thrombosis prophylaxis and. Location: UNITED KINGDOM , 56 years of age, After Heparin was administered, patient had the following side effects: heparin-induced thrombocytopenia, intestinal ischaemia, mesenteric artery thrombosis. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), DANAPAROID (View Danaparoid Review and Danaparoid Label ).

6715590-3 | Incision Site Haemorrhage
on May 06, 2010 Female patient from UNITED STATES , 68 years of age, weighting 183.0 lb, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: incision site haemorrhage. Heparin dosage: 15000 Units Once Iv. During the same period patient was treated with CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), RANITIDNE (View Ranitidne Review and Ranitidne Label ). Patient was hospitalized.

6715588-5 | Catheter Site Haemorrhage, Haematocrit Decreased, Haemoglobin Decreased, Incision Site Haemorrhage, Prothrombin Time Prolonged
on May 06, 2010 Male patient from UNITED STATES , 69 years of age, weighting 222.7 lb, was diagnosed with thrombosis prophylaxis and was treated with Heparin (View Usage). Patient had the following side effects: catheter site haemorrhage, haematocrit decreased, haemoglobin decreased, incision site haemorrhage, prothrombin time prolonged. Heparin dosage: 27,000 Units Once Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), DOCUSATE (View Docusate Review and Docusate Label ), ASPART (View Aspart Review and Aspart Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), SENNA (View Senna Review and Senna Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6708846-1 | Cardiac Arrest, Coronary Artery Occlusion
Patient was taking Heparin (View Usage). After Heparin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), coronary artery occlusion on May 03, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 125.7 lb, was diagnosed with percutaneous coronary intervention and. Heparin dosage: 5000 Units Q15 Minutes Iv X 3 Doses 4000 Units 3000 Units 20 Min Apart 2 Doses.

6708578-X | Cardiac Arrest, Heparin-induced Thrombocytopenia
Adverse event was reported on Apr 26, 2010 by a Male patient taking Heparin (View Usage) (Dosage: ) was diagnosed with cardiovascular event prophylaxis and. Location: UNITED STATES , 41 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), heparin-induced thrombocytopenia. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NITRATES (View Nitrates Review and Nitrates Label ), BETA BLOCKERS (View Beta-blockers Review and Beta-blockers Label ), PROTON PUMP INHIBITOR (View Proton Pump Inhibitor Review and Proton Pump Inhibitor Label ).

6702998-5 | Intracardiac Thrombus, Product Measured Potency Issue
on Apr 29, 2010 Male patient from UNITED STATES , 65 years of age, weighting 222.7 lb, was treated with Heparin (View Usage). Patient had the following side effects: intracardiac thrombus, product measured potency issue. Heparin dosage: .

6702996-1 | Product Quality Issue, Thrombosis In Device
on Apr 29, 2010 Male patient from UNITED STATES , 85 years of age, weighting 134.5 lb, was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: product quality issue, thrombosis in device. Heparin dosage: .

6700072-5 | Injection Site Inflammation, Pain In Extremity
Patient was taking Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: injection site inflammation, pain in extremity on Apr 27, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 202.0 lb, was diagnosed with thrombosis prophylaxis and. Heparin dosage: Every 4-6 Hrs Im.

6686844-4 | Accidental Overdose, Activated Partial Thromboplastin Time Prolonged, Areflexia, Haemorrhage Intracranial, Hypertension, Hypotension, Hypothermia
Adverse event was reported on Apr 16, 2010 by a Female patient taking Heparin (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 24.25 lb, Patient had the following side effects: accidental overdose, activated partial thromboplastin time prolonged, areflexia, haemorrhage intracranial, hypertension, hypotension, hypothermia (What is hypothermia?).

6683413-7 | Heparin-induced Thrombocytopenia, Intestinal Ischaemia, Thrombosis
on Apr 07, 2010 Male patient from UNITED KINGDOM , 56 years of age, was treated with Heparin (View Usage). After Heparin was administered, patient had the following side effects: heparin-induced thrombocytopenia, intestinal ischaemia, thrombosis. Heparin dosage: .

6678801-9 | Anti-platelet Antibody Positive, Atelectasis, Heparin-induced Thrombocytopenia, Pneumonia, Pyrexia, Urinary Tract Infection
on Apr 12, 2010 Male patient from UNITED STATES , 62 years of age, weighting 211.4 lb, was diagnosed with cerebrovascular accident and was treated with Heparin (View Usage). Patient experienced the following unwanted or unexpected effects: anti-platelet antibody positive, atelectasis, heparin-induced thrombocytopenia, pneumonia (What is pneumonia?), pyrexia, urinary tract infection (What is urinary tract infection?). Heparin dosage: 22.9 Iv. Patient was hospitalized.

6678291-6 | Activated Partial Thromboplastin Time Prolonged, Product Measured Potency Issue
Patient was taking Heparin (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, product measured potency issue on Apr 12, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 181.7 lb, was diagnosed with myocardial infarction and. Heparin dosage: Varied Continuous Infusion Iv.